Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302844 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of Imago Relationship Therapy
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT04302844: Completed NA study, sponsored by University of Pennsylvania.
NCT04302844 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302844, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The primary goal of this study, A Randomized Controlled Trial of Imago Relationship Therapy, is to evaluate the efficacy of Imago Relationship Therapy, a form of couples therapy.
Primary Outcome
The RQI (Lawrence, Barry, Brock, Bunde, Langer, Ro, et al., 2011) is semi-structured, behaviorally anchored individual interview that takes about 60 minutes to administer. The RQI provides an objective assessment of relationship quality as a dynamic dyadic construct across 5 dimensions: (a) quality of emotional intimacy in the relationship, (b) quality of the couple's sexual relationship, (c) quality of support transactions in the relationship, (d) quality of the couple's ability to share power
Interventions
- BEHAVIORAL Imago Relationship Therapy
- BEHAVIORAL Waitlist with Bibliotherapy followed by Workshop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2023-07-16 |
| Phase | NA |
What the finished NCT04302844 record still lists
NCT04302844 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Imago Relationship Therapy is the first listed.
NCT04302844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04302844 about?
NCT04302844 is a clinical study titled "A Randomized Controlled Trial of Imago Relationship Therapy". The primary goal of this study, A Randomized Controlled Trial of Imago Relationship Therapy, is to evaluate the efficacy of Imago Relationship Therapy, a form of couples therapy.
What is the current status of trial NCT04302844?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2019-03-04. Estimated completion is 2023-07-16.
What interventions are being tested in trial NCT04302844?
The interventions under investigation include: Imago Relationship Therapy (BEHAVIORAL), Waitlist with Bibliotherapy followed by Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT04302844?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04302844's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI